View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Banco Bilbao Vizcaya Argentaria, S.A.: Update following rating upgrade

Our credit view of Banco Bilbao Vizcaya Argentaria, S.A. reflects its strong profitability and high geographical diversification, with an elevated exposure to emerging markets

Banco Bilbao Vizcaya Argentaria SA: 1 director

A director at Banco Bilbao Vizcaya Argentaria SA sold 104,451 shares at 19.143EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...

Research Department
  • Research Department

IBERIAN DAILY 11 DECEMBER (ANÁLISIS BANCO SABADELL)

NEWS SUMMARY: CAF, INDRA, NATURGY. The FED cut rates, as expected With the Ibex remaining near highs, the lack of definition continued for European stock markets, awaiting the Fed’s decision. In the STOXX 600, Basic Resources and Banks led the gains whereas Autos and Construction (after an equity research firm cut Vinci’s recommendation) were the worst performers. On the macro side, in the US, as expected, the Fed cut interest rates by 25bps to 3.5%-3.75% (with 1 member in favour of cutting -5...

Research Department
  • Research Department

INFORME DIARIO 11 DICIEMBRE (ANÁLISIS BANCO SABADELL)

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CAF, INDRA, NATURGY. EUROPA: MUNICH RE. La FED cumple con el recorte de tipos Con el Ibex manteniéndose cerca de sus máximos las bolsas europeas continuaron una jornada más con cierta indefinición a la espera de catalizadores. En el STOXX 600, los mejores sectores fueron R. Básicos y Bancos mientras que Autos y Construcción (afectado por la rebaja de recomendación a Vinci por parte de una casa de análisis) fueron los que más cayeron. Por el lado m...

Andres Bolumburu
  • Andres Bolumburu

CAF: 9M’25 RESULTS AND CHANGE OF T.P. TO UNDER REVISION (ANÁLISIS BANC...

3Q'25 vs. 3Q'24 Results Sales: € 986.0 M (+17.7% vs. +10.0% BS(e) and +12.6% consensus); EBIT: € 47.0 M (+34.3% vs. +37.7% BS(e) and +42.9% consensus); Net Profit: € 27.0 M (+200.0% vs. +173.3% BS(e) and +211.1% consensus); 9M'25 vs. 9M'24 Results Sales: € 3.165 Bn (+8.5% vs. +6.3% BS(e) and +7.0% consensus); EBIT: € 161.0 M (+17.5% vs. +18.4% BS(e) and +19.7% consensus); Net Profit: € 100.0 M (+63.9% vs. +60.0% BS(e) and +65.6% consensus);

Carole Braudeau
  • Carole Braudeau

Credit Morning 10/30/2025

Avolta: Q3 sales and EBITDA came in a shade below expectations, but cash generation exceeded expectations. Faster growth rate in North America in October.|Constellium: Results ahead of expectations, good Q4 expected, and guidance upgraded once again|Eramet : Q3 25 revenue lower than expected|Finnair: Guidance range tightened downwards amid higher costs and weaker demand|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 30/10/2025

Avolta : un T3 un peu en-dessous des attentes sur le CA et l’Ebitda mais meilleure sur la génération de cash. Accélération de la croissance en octobre en Amérique du Nord.|Constellium: Results ahead of expectations, good Q4 expected, and guidance upgraded once again|Eramet : CA T3 25 plus faible que prévu|Finnair: Guidance range tightened downwards amid higher costs and weaker demand|

Andres Bolumburu
  • Andres Bolumburu

ENCE: 9M’25 RESULTS AND T.P. CUT (ANÁLISIS BANCO SABADELL)

3Q’25 vs. 3Q’24: Sales: € 180.9 M (-17.6% vs. -16.5% BS(e)); EBITDA: € 12.7 M (-75.4% vs. -79.1% BS(e)); EBIT: € -11.1 M (€ 26.1 M in 9M’24 vs. € -13.2 M BS(e)); Net Profit: € -15.1 M (€ 14.3 M in 9M’24 vs. € -17.7 M BS(e)). 9M’25 vs. 9M’24: Sales: € 560.1 M (-16.2% vs. -15.8% BS(e)); EBITDA: € 70.7 M (-53.6% vs. -54.9% BS(e)); EBIT: € -1.1 M (€ 71.1 M in 9M’24 vs. € -3.2 M BS(e)); Net Profit: € -22.0 M (€ 40.8 M in 9M’24 vs. € -24.6 M BS(e)).

Andres Bolumburu
  • Andres Bolumburu

ENCE: RDOS. 9MESES’25 Y CAMBIO DE P.O. A LA BAJA (ANÁLISIS BANCO SABAD...

Rdos. 3T'25 vs 3T'24: Ventas: 180,9 M euros (-17,6% vs -16,5% BS(e)); EBITDA: 12,7 M euros (-75,4% vs -79,1% BS(e)); EBIT: -11,1 M euros (26,1 M euros en 9meses'24 vs -13,2 M euros BS(e)); BDI: -15,1 M euros (14,3 M euros en 9meses'24 vs -17,7 M euros BS(e)). Rdos. 9meses'25 vs 9meses'24: Ventas: 560,1 M euros (-16,2% vs -15,8% BS(e)); EBITDA: 70,7 M euros (-53,6% vs -54,9% BS(e)); EBIT: -1,1 M euros (71,1 M euros en 9meses'24 vs -3,2 M euros BS(e)); BDI: -22,0 M euros (40,8 M euros en 9meses'24...

Research Department
  • Research Department

IBERIAN DAILY 29 OCTOBER + 3Q’25 RESULTS. HIGHLIGHTS AND REST OF PREVI...

NEWS SUMMARY: COLONIAL, ENAGÁS, ENCE, ENDESA, FERROVIAL, REDEIA, SANTANDER. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 3Q’25 results to be released over the coming days in Spain. Ibex 35 above 16,080 Mixed bag on European stock markets with the “periphery” and the FTSE in positive numbers, compared to the core indices and the Swiss SMI in the red. In the STOXX 600, the big...

Research Department
  • Research Department

INFORME DIARIO 29 OCTUBRE + RDOS. ESPAÑA Y EUROPA 3T’25. IDEAS DESTACA...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ENAGAS, ENCE, ENDESA, FERROVIAL, INMOBILIARIA COLONIAL, REDEIA, SANTANDER. EUROPA: ADIDAS, MERCEDES, NOKIA. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’25 que se publicarán en España y Europa en los próximos días. El Ibex 35 supera los 16.080 puntos Cierre mixto en las bolsas europeas con la “perife...

Banco Bilbao Vizcaya Argentaria, S.A.: Update following rating upgrade

Our credit view of this issuer reflects its strong profitability and geographical diversification, against its modest capital and high use of market funds.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch